JDRF News Blog - Juvenation

| |

JDRF News Blog

New Study Discovers Cause of Pain in Diabetic Neuropathy

Posted 4 days ago

by Gary
- 0 Comments
Diabetic neuropathy , or nerve damage, is one of the most painful complications faced by people with diabetes. Over time, high blood sugar associated with diabetes may lead to nerve damage. In the legs and feet, this nerve damage frequently results in...
JDRF News Blog

JDRF Uses Clinical Trials Connection to Play Matchmaker

Posted 15 days ago

by Michael
- 1 Comments
Recently, the Wall Street Journal published an article about matching patients with their ideal clinical trials, which focused on the growing trend of patient advocacy groups and their efforts to encourage clinical trial participation. In addition to...
JDRF News Blog

T1D reversed in mice using engineered gut bacteria

Posted 25 days ago

by Tara Wilcox-Ghanoonparvar
- 1 Comments
An oral treatment of harmless, specially engineered gut bacteria was able to reverse type 1 diabetes (T1D) in experimental mice, according to a partially JDRF-funded study in Belgium. The findings , which were recently published in the April edition of...
JDRF News Blog

New Industry Partnership Paves the Way for Drug Development for Beta Cell Regeneration

Posted 1 month ago

by Liz Cuebas
- 0 Comments
JDRF industry partner NGM Biopharmaceuticals, Inc., recently announced a new partnership with Daiichi Sankyo Company, Ltd., a Japanese pharmaceutical company. The partnership will focus on discovering and developing drugs to regenerate pancreatic beta...
JDRF News Blog

MRI Scanning Technique Predicts T1D Onset

Posted 1 month ago

by Shana
- 0 Comments
In a recent study published in the current issue of Nature Immunology , a JDRF-funded team led by Dr. Diane Mathis from the Harvard Medical School and Massachusetts General Hospital developed a technique that uses MRI and nanoparticles for predicting...
JDRF News Blog

Novel technology may help new beta cells survive

Posted 2 months ago

by Gary
- 1 Comments
Replacing the body’s insulin-producing beta cells is one potential method for curing type 1 diabetes (T1D). Researchers are attempting to solve a number of challenges to make beta cell replacement a reality. These include: overcoming the misguided...
JDRF News Blog

Key Component of Artificial Pancreas Shown Successful in Reducing Hypoglycemia in People with T1D

Posted 2 months ago

by Tara Wilcox-Ghanoonparvar
- 2 Comments
In a study published this month in Diabetes Technology & Therapeutics , researchers concluded that the automatic suspension of insulin delivery by a low glucose suspend (LGS) system greatly reduces the severity and duration of hypoglycemia (extreme...
JDRF News Blog

JDRF Part of a Growing Trend of Nonprofits Leading Drug Development

Posted 3 months ago

by Michael
- 0 Comments
Nonprofit organizations focused on disease research are transforming their traditional roles, and emerging as key players in accelerating the development of better treatments and cures, according to a recent report by the Harvard Stem Cell Institute ...
JDRF News Blog

Study Helps Explain Activity of Anti-CD3 in Treating or Preventing Type 1 Diabetes

Posted 3 months ago

by Joana Casas
- 0 Comments
JDRF-funded scientists at Yale University recently found a mechanism of action by which teplizumab, an anti-CD3 antibody may be working as an immune therapy for T1D. Currently, once T1D starts to develop, there’s no intervention developed to stop...
JDRF News Blog

New study may help determine risk of kidney disease for people with diabetes

Posted 3 months ago

by Gary
- 0 Comments
Nearly 20 years ago, the Diabetes Control and Complications Trial (DCCT) proved that keeping tight control over blood sugar levels can help prevent or delay the onset of complications for people with diabetes. Since then, researchers have continued to...
JDRF News Blog

JDRF-Funded Project Identifies Cell that Triggers T1D

Posted 3 months ago

by Liz Cuebas
- 0 Comments
JDRF-funded researchers at the La Jolla Institute of Allergy and Immunology in San Diego have become the first researchers to successfully determine which kind of T-cells are responsible for the autoimmune attack on the insulin-producing beta cells in...
JDRF News Blog

Study on Economic Impact of Diabetes doesn’t Distinguish between T1D and T2D

Posted 4 months ago

by Shana
- 1 Comments
One of the common frustrations for people with diabetes is the lack of understanding about the difference between type 1 diabetes (T1D) and type 2 diabetes (T2D). T1D is an autoimmune disease which affects as many as 3 million Americans, is not caused...
JDRF News Blog

A look back on recent research progress as 2012 draws near

Posted 5 months ago

by Tara Wilcox-Ghanoonparvar
- 0 Comments
As we inch toward the end of 2011, a look back over the past few months shows a great deal of progress in JDRF’s efforts toward curing, treating, and preventing type 1 diabetes (T1D) and its complications. Check out the latest key advances from...
JDRF News Blog

Diabetes in Action: New visualization technique allows researchers to see the destruction of insulin-producing beta cells

Posted 5 months ago

by Michael
- 0 Comments
Last week, JDRF-funded researchers from the La Jolla Institute for Allergy and Immunology in San Diego, California announced that they had created the first 3-dimensional movies depicting the destruction of insulin-producing beta cells – the process...
JDRF News Blog

Progress on the Artificial Pancreas

Posted 5 months ago

by Jeffrey Brewer
- 1 Comments
I’m pleased to share the news that on Thursday , December 1, the U.S. Food and Drug Administration (FDA) issued artificial pancreas (AP) draft guidance. While the draft guidance is still under review, our initial analysis suggests that it affirmatively...
JDRF News Blog

Preliminary Data from Phase 3 Clinical Trial of DiaPep277 Yields Positive Results in Newly Diagnosed People with Type 1 Diabetes

Posted 5 months ago

by Joana Casas
- 0 Comments
Andromeda Biotech, an Israel-based biotechnology company, recently announced that its Phase 3 study of a novel immunotherapy agent, DiaPep277, met its primary and secondary endpoints of insulin preservation and improvement in HbA1c levels among newly...
JDRF News Blog

Newly Discovered Blood Test May Help Identify Type 1 Diabetes Before Symptoms Appear

Posted 6 months ago

by Gary
- 0 Comments
As new cases of type 1 diabetes (T1D) increase worldwide , JDRF has continued to focus on preventing T1D in those at risk. By the time symptoms of T1D appear, however, the destruction of insulin producing beta cells may have already been occurring for...
JDRF News Blog

Endocrine Society Releases New Guidelines on Continuous Glucose Monitoring

Posted 6 months ago

by Shana
- 0 Comments
People with type 1 diabetes must carefully balance insulin doses with eating and daily activities throughout the day and night – and still run the risk of dangerous high or low blood sugar levels. To help manage this daily challenge, a continuous...
JDRF News Blog

Hormone that Helps Regulate Insulin Production Could Lead to Better Treatments for Type 1 Diabetes

Posted 7 months ago

by Liz Cuebas
- 0 Comments
Researchers from the Salk Institute have identified molecular switches that regulate islet beta cell survival and insulin production. These findings could help lead to development of new diabetes drugs. The JDRF-funded Salk researchers, led by Dr. Marc...
JDRF News Blog

Study Shows Urine Test Can Help Distinguish Type 1 Diabetes from MODY

Posted 7 months ago

by Joana Casas
- 0 Comments
A urine test that can be taken at home could help differentiate a diagnosis of type 1 diabetes from a genetic form of the disease, called maturity-onset diabetes of youth (MODY). Researchers from the Peninsula Medical School in United Kingdom, presented...
JDRF News Blog

Three-Way Research Partnership Could Hold Benefits for Both Type 1 Diabetes and Multiple Sclerosis

Posted 8 months ago

by Tara Wilcox-Ghanoonparvar
- 0 Comments
Scientists have found that certain links may exist between different autoimmune disorders, allowing research on one disease to shed light on another. One such potential link, between type 1 diabetes and multiple sclerosis, led to a three-way partnership...
JDRF News Blog

Reaching out: JDRF rolls out next Toolkit for adults with type 1 diabetes

Posted 8 months ago

by Michael
- 0 Comments
Currently, adults make up 85 percent of those living with type 1 diabetes. And every year in the United States alone, roughly half of the 30,000 new cases of type 1 diabetes are adults over the age of 18. So for anyone who has spent time on Juvenation...
JDRF News Blog

JDRF Participates in Annual Children with Diabetes Friends for Life Conference

Posted 10 months ago

by Andrew Bell
- 0 Comments
Well over 3,000 kids, families and adults with type 1 diabetes gathered in Orlando earlier this month for the 12 th annual Children with Diabetes (CWD) Friends for Life (FFL) Conference. JDRF has been participating in this event for the last nine years...
JDRF News Blog

Update on New Type 1 Diabetes Clinical Trials

Posted 10 months ago

by Liz Cuebas
- 0 Comments
At the recent American Diabetes Association 71 st Scientific Sessions in San Diego the results of several clinical trials focused on finding a cure for type 1 diabetes were announced. Most of these trials tested drugs administered to people with type...
JDRF News Blog

Life Expectancy for People with Type 1 Diabetes Improves Dramatically

Posted 10 months ago

by Gary
- 2 Comments
While we have yet to achieve a cure for type 1 diabetes, treatment has improved vastly over the past few decades. Tools such as blood glucose meters, HbA1c tests, faster and longer acting insulins, insulin pumps, and continuous glucose monitors weren’t...